Nkarta Inc (NKTX) is a biotechnology company listed on NASDAQ.
Latest reported NKTX revenue for 2025-12-31 was $0. Net income was -$104.1M. NKTX currently screens at market cap $188.9M.
Use this NKTX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the NKTX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the NKTX SEC filings page. Lician reads the product cache first so this HTML stays unique to Nkarta Inc even when a live quote feed is slow.
Latest cached year on this hub. Full NKTX income, balance, and cash tables.